MY140504A - Statin-mmp inhibitor combinations - Google Patents
Statin-mmp inhibitor combinationsInfo
- Publication number
- MY140504A MY140504A MYPI99000951A MYPI9900951A MY140504A MY 140504 A MY140504 A MY 140504A MY PI99000951 A MYPI99000951 A MY PI99000951A MY PI9900951 A MYPI9900951 A MY PI9900951A MY 140504 A MY140504 A MY 140504A
- Authority
- MY
- Malaysia
- Prior art keywords
- statin
- mmp inhibitor
- inhibitor combinations
- combinations
- mmp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7826598P | 1998-03-17 | 1998-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY140504A true MY140504A (en) | 2009-12-31 |
Family
ID=22142950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI99000951A MY140504A (en) | 1998-03-17 | 1999-03-15 | Statin-mmp inhibitor combinations |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1063991A1 (ko) |
| JP (1) | JP2002506818A (ko) |
| KR (1) | KR20010041916A (ko) |
| AR (1) | AR018113A1 (ko) |
| AU (1) | AU1591699A (ko) |
| BR (1) | BR9815745A (ko) |
| CA (1) | CA2309588A1 (ko) |
| CO (1) | CO5070670A1 (ko) |
| GT (1) | GT199900039A (ko) |
| HN (1) | HN1999000029A (ko) |
| MY (1) | MY140504A (ko) |
| NZ (1) | NZ505994A (ko) |
| PA (1) | PA8469001A1 (ko) |
| PE (1) | PE20000348A1 (ko) |
| SV (1) | SV1999000026A (ko) |
| UY (1) | UY25436A1 (ko) |
| WO (1) | WO1999047138A1 (ko) |
| ZA (1) | ZA992106B (ko) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| RU2410118C2 (ru) | 2004-12-15 | 2011-01-27 | Зольвай Фармасьютиклз Гмбх | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ИНГИБИТОРЫ НЭП (НЕЙТРАЛЬНОЙ ЭНДОПЕПТИДАЗЫ), ИНГИБИТОРЫ ЭНДОГЕННОЙ ПРОДУЦИРУЮЩЕЙ ЭНДОТЕЛИН СИСТЕМЫ И ИНГИБИТОРЫ ГМГ (ГИДРОКСИМЕТИЛГЛУТАРИЛ)СоА РЕДУКТАЗЫ |
| SG166829A1 (en) * | 2005-11-08 | 2010-12-29 | Ranbaxy Lab Ltd | Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| WO2010005389A1 (en) * | 2008-07-11 | 2010-01-14 | Forskarpatent I Syd Ab | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9611410A (pt) * | 1995-11-02 | 1999-01-05 | Warner Lambert Co | Método e composição farmacêutica para regular a concentração de lipídios |
| PL186416B1 (pl) * | 1996-05-17 | 2004-01-30 | Warner Lambert Co | Związek bifenylosulfonamidowy i preparat farmaceutyczny zawierający ten związek |
| IL128545A0 (en) * | 1996-12-09 | 2000-01-31 | Warner Lambert Co | Method for treating and preventing heart failure and ventricular dilatation |
| TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
| GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Application Discontinuation
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Application Discontinuation
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8469001A1 (es) | 2002-09-17 |
| AU1591699A (en) | 1999-10-11 |
| CA2309588A1 (en) | 1999-09-23 |
| BR9815745A (pt) | 2000-11-14 |
| NZ505994A (en) | 2003-10-31 |
| JP2002506818A (ja) | 2002-03-05 |
| SV1999000026A (es) | 2000-01-18 |
| UY25436A1 (es) | 2001-10-25 |
| CO5070670A1 (es) | 2001-08-28 |
| GT199900039A (es) | 2000-09-06 |
| HN1999000029A (es) | 1999-09-29 |
| KR20010041916A (ko) | 2001-05-25 |
| ZA992106B (en) | 1999-09-30 |
| AR018113A1 (es) | 2001-10-31 |
| WO1999047138A1 (en) | 1999-09-23 |
| EP1063991A1 (en) | 2001-01-03 |
| PE20000348A1 (es) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300179I2 (nl) | Geneesmiddelvoorlopers van trombineremmers. | |
| YU15299A (sh) | Farmaceutski sastavi | |
| ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
| MY125467A (en) | Olanzapine dihydrate d | |
| WO1999054286A3 (en) | Btk inhibitors and methods for their identification and use | |
| NO990760D0 (no) | 1,4-heterocykliske metallproteaseinhibitorer | |
| UA34466C2 (uk) | Засіб для несистемної боротьби з паразитуючими комахами | |
| AU7031500A (en) | Therapeutic quinazoline compounds | |
| UA85368C2 (ru) | Применение остеопонтина для лечения и/или предотвращения неврологического заболевания | |
| ES2191830T3 (es) | Inhibidores de trombina. | |
| EP1776954A3 (en) | The use of inhibitors of the renin-angiotensin system for the treatment of stroke | |
| AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
| ZA9811629B (en) | The use of MMP inhibitors for the treatment of ocular angiogenesis. | |
| YU34199A (sh) | Primena inhibitora gastrointestinalne lipaze | |
| MY118381A (en) | Statin-carboxyalkylether combinations | |
| GB9907571D0 (en) | Compounds | |
| ES2186807T3 (es) | Inhibidores de trombina. | |
| ZA985182B (en) | Farnesyl transferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer. | |
| NZ320259A (en) | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors | |
| MY140504A (en) | Statin-mmp inhibitor combinations | |
| IL139144A0 (en) | Mycobacterial inhibitors | |
| AU1103699A (en) | Use of an inhibitor of the dephosphorylation of darpp-32 for treating schizophrenia | |
| EP1351680B8 (fr) | Utilisation de l'anethole-dithiolethione dans la prevention et le traitement de la tenotoxicite induite par un medicament | |
| AU1653100A (en) | Use of diminazene-di-aceturate for treating malaria | |
| ECSP992885A (es) | Combinaciones de estatina-inhibidor de mmp |